AI Hacking - How Hackers Use Artifical Intelligence in Cyberattacks

Read Now
We utilize artificial intelligence for site translations, and while we strive for accuracy, they may not always be 100% precise. Your understanding is appreciated.

Cisco joins the OPSWAT certification program

by Hamid Karimi
Share this Post

Eight new anti-malware products were certified by OPSWAT in May 2019 at Gold, Silver and Bronze levels. The noteworthy addition to the growing list of our partners is Cisco that has shown impressive results in recent AV-Comparatives tests. The following table lists Anti-Malware products that were certified in May.

#

Certified Product

Level

Category

1

Cisco Advanced Malware Protection (AMP) for Endpoints 6.x for Windows

Silver

Anti-Malware

2

Seqrite Endpoint Security Cloud 17.x for Windows (Quick Heal)

Gold

Anti-Malware

3

Seqrite Endpoint Security Cloud 17.x for Mac (Quick Heal)

Bronze

Anti-Malware

4

IObit Malware Fighter 7.x for Windows

Silver

Anti-Malware

5

Trend Micro Apex One 14.x for Windows

Silver

Anti-Malware

6

F-Secure Client Security 13.x for Windows

Silver

Anti-Malware

7

F-Secure Client Security Premium 13.x for Windows

Silver

Anti-Malware

8

Quick Heal Total Security for Mac 2.x

Bronze

Anti-Malware


OPSWAT Certified Security Applications Program
ensures CASB, NAC, SSL-VPN, and IDaaS compatibility with the top market leading access control solutions from vendors such as OPSWAT, Cisco, HP, F5, Pulse Secure, LogMeIn, Palo Alto Networks, IBM, VMware, Citrix and many others, supporting 100 million endpoints while ensuring compatibility with over 200 million enterprise-connected devices globally.

To learn more about the OPSWAT Certified Security Applications Program and certified solutions, check out the certification criteria, or submit an application for certification.

Lastly, understand how MetaAcces can help ensure device security compliance.

Stay Up-to-Date With OPSWAT!

Sign up today to receive the latest company updates, stories, event info, and more.